PREVIOUS
✖
BIRSA 101
November 24 , 2025
14 hrs 0 min
39
0
- India launched its first indigenous CRISPR-based gene therapy for Sickle Cell Disease named BIRSA 101.
- The therapy is dedicated to Bhagwan Birsa Munda, marking his 150th anniversary.
- Sickle Cell Disease primarily affects tribal populations in central and eastern India.
- Sickle Cell Disease (SCD) is a genetic blood disorder.
- The red blood cells become crescent-shaped, causing reduced oxygen transport, severe anaemia, pain, and organ damage.
Leave a Reply
Your Comment is awaiting moderation.